Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | w1a_vs_wt_vs_wt.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp_repos |
| Phenotype | w1a_vs_wt.cls#ago1w1a_versus_ago1gfp_repos |
| Upregulated in class | ago1w1a |
| GeneSet | KEGG_FOCAL_ADHESION |
| Enrichment Score (ES) | 0.35451937 |
| Normalized Enrichment Score (NES) | 1.4053378 |
| Nominal p-value | 0.009063444 |
| FDR q-value | 0.28114408 |
| FWER p-Value | 0.994 |
| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | LAMA4 | NA | LAMA4 Entrez, Source | laminin, alpha 4 | 124 | 2.938 | 0.0163 | Yes |
| 2 | ITGA2 | NA | ITGA2 Entrez, Source | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 148 | 2.720 | 0.0364 | Yes |
| 3 | BIRC3 | NA | BIRC3 Entrez, Source | baculoviral IAP repeat-containing 3 | 182 | 2.484 | 0.0542 | Yes |
| 4 | TNXB | NA | TNXB Entrez, Source | tenascin XB | 186 | 2.472 | 0.0735 | Yes |
| 5 | PIP5K1C | NA | PIP5K1C Entrez, Source | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | 192 | 2.426 | 0.0923 | Yes |
| 6 | BCAR1 | NA | BCAR1 Entrez, Source | breast cancer anti-estrogen resistance 1 | 318 | 1.914 | 0.1005 | Yes |
| 7 | ITGA10 | NA | ITGA10 Entrez, Source | integrin, alpha 10 | 333 | 1.876 | 0.1145 | Yes |
| 8 | ITGA5 | NA | ITGA5 Entrez, Source | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 342 | 1.848 | 0.1286 | Yes |
| 9 | LAMB3 | NA | LAMB3 Entrez, Source | laminin, beta 3 | 343 | 1.846 | 0.1431 | Yes |
| 10 | COL6A2 | NA | COL6A2 Entrez, Source | collagen, type VI, alpha 2 | 350 | 1.826 | 0.1572 | Yes |
| 11 | PIK3R1 | NA | PIK3R1 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | 366 | 1.786 | 0.1705 | Yes |
| 12 | FLNA | NA | FLNA Entrez, Source | filamin A, alpha (actin binding protein 280) | 410 | 1.695 | 0.1814 | Yes |
| 13 | MYL5 | NA | MYL5 Entrez, Source | myosin, light chain 5, regulatory | 415 | 1.685 | 0.1945 | Yes |
| 14 | ITGB4 | NA | ITGB4 Entrez, Source | integrin, beta 4 | 479 | 1.572 | 0.2034 | Yes |
| 15 | ZYX | NA | ZYX Entrez, Source | zyxin | 538 | 1.501 | 0.2120 | Yes |
| 16 | ITGB8 | NA | ITGB8 Entrez, Source | integrin, beta 8 | 557 | 1.476 | 0.2226 | Yes |
| 17 | PAK6 | NA | PAK6 Entrez, Source | p21(CDKN1A)-activated kinase 6 | 607 | 1.408 | 0.2310 | Yes |
| 18 | VWF | NA | VWF Entrez, Source | von Willebrand factor | 689 | 1.332 | 0.2370 | Yes |
| 19 | JUN | NA | JUN Entrez, Source | jun oncogene | 718 | 1.312 | 0.2458 | Yes |
| 20 | COL4A2 | NA | COL4A2 Entrez, Source | collagen, type IV, alpha 2 | 794 | 1.252 | 0.2515 | Yes |
| 21 | FN1 | NA | FN1 Entrez, Source | fibronectin 1 | 803 | 1.244 | 0.2608 | Yes |
| 22 | THBS1 | NA | THBS1 Entrez, Source | thrombospondin 1 | 860 | 1.202 | 0.2672 | Yes |
| 23 | ACTG1 | NA | ACTG1 Entrez, Source | actin, gamma 1 | 887 | 1.181 | 0.2751 | Yes |
| 24 | SRC | NA | SRC Entrez, Source | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 901 | 1.176 | 0.2836 | Yes |
| 25 | LAMC2 | NA | LAMC2 Entrez, Source | laminin, gamma 2 | 917 | 1.160 | 0.2919 | Yes |
| 26 | ITGA3 | NA | ITGA3 Entrez, Source | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 961 | 1.138 | 0.2985 | Yes |
| 27 | EGFR | NA | EGFR Entrez, Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1042 | 1.098 | 0.3027 | Yes |
| 28 | COL6A1 | NA | COL6A1 Entrez, Source | collagen, type VI, alpha 1 | 1054 | 1.091 | 0.3107 | Yes |
| 29 | MYLK2 | NA | MYLK2 Entrez, Source | myosin light chain kinase 2, skeletal muscle | 1100 | 1.069 | 0.3166 | Yes |
| 30 | PDGFA | NA | PDGFA Entrez, Source | platelet-derived growth factor alpha polypeptide | 1146 | 1.048 | 0.3224 | Yes |
| 31 | FLNB | NA | FLNB Entrez, Source | filamin B, beta (actin binding protein 278) | 1220 | 1.011 | 0.3263 | Yes |
| 32 | LAMA5 | NA | LAMA5 Entrez, Source | laminin, alpha 5 | 1326 | 0.975 | 0.3281 | Yes |
| 33 | CCND3 | NA | CCND3 Entrez, Source | cyclin D3 | 1347 | 0.964 | 0.3346 | Yes |
| 34 | PIK3CD | NA | PIK3CD Entrez, Source | phosphoinositide-3-kinase, catalytic, delta polypeptide | 1572 | 0.890 | 0.3291 | Yes |
| 35 | RAC2 | NA | RAC2 Entrez, Source | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 1748 | 0.839 | 0.3260 | Yes |
| 36 | ACTN1 | NA | ACTN1 Entrez, Source | actinin, alpha 1 | 1755 | 0.838 | 0.3323 | Yes |
| 37 | ACTB | NA | ACTB Entrez, Source | actin, beta | 1765 | 0.836 | 0.3384 | Yes |
| 38 | HRAS | NA | HRAS Entrez, Source | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 1799 | 0.831 | 0.3431 | Yes |
| 39 | COL4A1 | NA | COL4A1 Entrez, Source | collagen, type IV, alpha 1 | 1818 | 0.825 | 0.3486 | Yes |
| 40 | PAK4 | NA | PAK4 Entrez, Source | p21(CDKN1A)-activated kinase 4 | 1898 | 0.808 | 0.3506 | Yes |
| 41 | CAPN2 | NA | CAPN2 Entrez, Source | calpain 2, (m/II) large subunit | 2083 | 0.769 | 0.3464 | Yes |
| 42 | COL5A1 | NA | COL5A1 Entrez, Source | collagen, type V, alpha 1 | 2145 | 0.755 | 0.3490 | Yes |
| 43 | ACTN4 | NA | ACTN4 Entrez, Source | actinin, alpha 4 | 2321 | 0.719 | 0.3449 | Yes |
| 44 | PRKCG | NA | PRKCG Entrez, Source | protein kinase C, gamma | 2351 | 0.711 | 0.3489 | Yes |
| 45 | VAV2 | NA | VAV2 Entrez, Source | vav 2 oncogene | 2382 | 0.706 | 0.3528 | Yes |
| 46 | PAK3 | NA | PAK3 Entrez, Source | p21 (CDKN1A)-activated kinase 3 | 2450 | 0.694 | 0.3545 | Yes |
| 47 | BAD | NA | BAD Entrez, Source | BCL2-antagonist of cell death | 2764 | 0.637 | 0.3421 | No |
| 48 | ITGA6 | NA | ITGA6 Entrez, Source | integrin, alpha 6 | 3033 | 0.591 | 0.3319 | No |
| 49 | COL5A3 | NA | COL5A3 Entrez, Source | collagen, type V, alpha 3 | 3048 | 0.589 | 0.3357 | No |
| 50 | MYLK | NA | MYLK Entrez, Source | myosin, light chain kinase | 3171 | 0.571 | 0.3334 | No |
| 51 | BIRC2 | NA | BIRC2 Entrez, Source | baculoviral IAP repeat-containing 2 | 3377 | 0.540 | 0.3263 | No |
| 52 | ERBB2 | NA | ERBB2 Entrez, Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 3754 | 0.491 | 0.3092 | No |
| 53 | VASP | NA | VASP Entrez, Source | vasodilator-stimulated phosphoprotein | 3873 | 0.478 | 0.3064 | No |
| 54 | SHC1 | NA | SHC1 Entrez, Source | SHC (Src homology 2 domain containing) transforming protein 1 | 4000 | 0.462 | 0.3031 | No |
| 55 | TLN2 | NA | TLN2 Entrez, Source | talin 2 | 4079 | 0.450 | 0.3023 | No |
| 56 | VCL | NA | VCL Entrez, Source | vinculin | 4090 | 0.448 | 0.3053 | No |
| 57 | FLNC | NA | FLNC Entrez, Source | filamin C, gamma (actin binding protein 280) | 4132 | 0.442 | 0.3065 | No |
| 58 | BRAF | NA | BRAF Entrez, Source | v-raf murine sarcoma viral oncogene homolog B1 | 4135 | 0.442 | 0.3098 | No |
| 59 | COL2A1 | NA | COL2A1 Entrez, Source | collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) | 4175 | 0.438 | 0.3111 | No |
| 60 | TNR | NA | TNR Entrez, Source | tenascin R (restrictin, janusin) | 4358 | 0.416 | 0.3043 | No |
| 61 | ITGB6 | NA | ITGB6 Entrez, Source | integrin, beta 6 | 4395 | 0.412 | 0.3055 | No |
| 62 | CCND1 | NA | CCND1 Entrez, Source | cyclin D1 | 4440 | 0.407 | 0.3063 | No |
| 63 | ITGA1 | NA | ITGA1 Entrez, Source | integrin, alpha 1 | 4689 | 0.384 | 0.2955 | No |
| 64 | MAPK3 | NA | MAPK3 Entrez, Source | mitogen-activated protein kinase 3 | 4770 | 0.376 | 0.2940 | No |
| 65 | VAV1 | NA | VAV1 Entrez, Source | vav 1 oncogene | 4895 | 0.363 | 0.2900 | No |
| 66 | CAV3 | NA | CAV3 Entrez, Source | caveolin 3 | 4947 | 0.356 | 0.2899 | No |
| 67 | PIK3R3 | NA | PIK3R3 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) | 5162 | 0.335 | 0.2807 | No |
| 68 | PAK1 | NA | PAK1 Entrez, Source | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 5493 | 0.303 | 0.2647 | No |
| 69 | COL6A3 | NA | COL6A3 Entrez, Source | collagen, type VI, alpha 3 | 5591 | 0.296 | 0.2616 | No |
| 70 | LAMC1 | NA | LAMC1 Entrez, Source | laminin, gamma 1 (formerly LAMB2) | 5595 | 0.296 | 0.2638 | No |
| 71 | COL1A2 | NA | COL1A2 Entrez, Source | collagen, type I, alpha 2 | 5608 | 0.295 | 0.2655 | No |
| 72 | LAMB4 | NA | LAMB4 Entrez, Source | laminin, beta 4 | 6080 | 0.256 | 0.2413 | No |
| 73 | AKT2 | NA | AKT2 Entrez, Source | v-akt murine thymoma viral oncogene homolog 2 | 6144 | 0.250 | 0.2397 | No |
| 74 | PXN | NA | PXN Entrez, Source | paxillin | 6363 | 0.232 | 0.2294 | No |
| 75 | DIAPH1 | NA | DIAPH1 Entrez, Source | diaphanous homolog 1 (Drosophila) | 6420 | 0.227 | 0.2281 | No |
| 76 | RAPGEF1 | NA | RAPGEF1 Entrez, Source | Rap guanine nucleotide exchange factor (GEF) 1 | 6515 | 0.219 | 0.2246 | No |
| 77 | PPP1CA | NA | PPP1CA Entrez, Source | protein phosphatase 1, catalytic subunit, alpha isoform | 6912 | 0.187 | 0.2040 | No |
| 78 | CRKL | NA | CRKL Entrez, Source | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 7119 | 0.172 | 0.1939 | No |
| 79 | ITGA8 | NA | ITGA8 Entrez, Source | integrin, alpha 8 | 7180 | 0.167 | 0.1919 | No |
| 80 | MYL2 | NA | MYL2 Entrez, Source | myosin, light chain 2, regulatory, cardiac, slow | 7327 | 0.157 | 0.1850 | No |
| 81 | ITGB7 | NA | ITGB7 Entrez, Source | integrin, beta 7 | 7628 | 0.134 | 0.1694 | No |
| 82 | MYL10 | NA | 7730 | 0.128 | 0.1648 | No | ||
| 83 | MYL12A | NA | 7897 | 0.115 | 0.1565 | No | ||
| 84 | VEGFA | NA | 7903 | 0.115 | 0.1571 | No | ||
| 85 | AKT1 | NA | AKT1 Entrez, Source | v-akt murine thymoma viral oncogene homolog 1 | 7922 | 0.113 | 0.1570 | No |
| 86 | ILK | NA | ILK Entrez, Source | integrin-linked kinase | 8167 | 0.095 | 0.1441 | No |
| 87 | HGF | NA | HGF Entrez, Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 8193 | 0.093 | 0.1435 | No |
| 88 | SHC3 | NA | SHC3 Entrez, Source | SHC (Src homology 2 domain containing) transforming protein 3 | 8245 | 0.090 | 0.1414 | No |
| 89 | ELK1 | NA | ELK1 Entrez, Source | ELK1, member of ETS oncogene family | 8346 | 0.082 | 0.1364 | No |
| 90 | FLT4 | NA | FLT4 Entrez, Source | fms-related tyrosine kinase 4 | 8443 | 0.076 | 0.1317 | No |
| 91 | TLN1 | NA | TLN1 Entrez, Source | talin 1 | 8729 | 0.056 | 0.1163 | No |
| 92 | ROCK1 | NA | ROCK1 Entrez, Source | Rho-associated, coiled-coil containing protein kinase 1 | 8743 | 0.055 | 0.1160 | No |
| 93 | PIK3CA | NA | PIK3CA Entrez, Source | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 8784 | 0.052 | 0.1142 | No |
| 94 | COL4A6 | NA | COL4A6 Entrez, Source | collagen, type IV, alpha 6 | 8853 | 0.047 | 0.1108 | No |
| 95 | PAK2 | NA | PAK2 Entrez, Source | p21 (CDKN1A)-activated kinase 2 | 8915 | 0.042 | 0.1077 | No |
| 96 | IGF1 | NA | IGF1 Entrez, Source | insulin-like growth factor 1 (somatomedin C) | 9306 | 0.014 | 0.0861 | No |
| 97 | COMP | NA | COMP Entrez, Source | cartilage oligomeric matrix protein | 9348 | 0.011 | 0.0839 | No |
| 98 | THBS2 | NA | THBS2 Entrez, Source | thrombospondin 2 | 9483 | 0.002 | 0.0765 | No |
| 99 | SHC2 | NA | SHC2 Entrez, Source | SHC (Src homology 2 domain containing) transforming protein 2 | 9647 | 0.000 | 0.0674 | No |
| 100 | MAP2K1 | NA | MAP2K1 Entrez, Source | mitogen-activated protein kinase kinase 1 | 9745 | -0.001 | 0.0620 | No |
| 101 | PDGFB | NA | PDGFB Entrez, Source | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 9832 | -0.008 | 0.0573 | No |
| 102 | RAC1 | NA | RAC1 Entrez, Source | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 9857 | -0.010 | 0.0560 | No |
| 103 | CCND2 | NA | CCND2 Entrez, Source | cyclin D2 | 10056 | -0.023 | 0.0452 | No |
| 104 | MYLPF | NA | MYLPF Entrez, Source | - | 10088 | -0.024 | 0.0437 | No |
| 105 | IGF1R | NA | IGF1R Entrez, Source | insulin-like growth factor 1 receptor | 10119 | -0.027 | 0.0422 | No |
| 106 | ITGA9 | NA | ITGA9 Entrez, Source | integrin, alpha 9 | 10122 | -0.027 | 0.0423 | No |
| 107 | MAPK8 | NA | MAPK8 Entrez, Source | mitogen-activated protein kinase 8 | 10132 | -0.028 | 0.0420 | No |
| 108 | CRK | NA | CRK Entrez, Source | v-crk sarcoma virus CT10 oncogene homolog (avian) | 10244 | -0.034 | 0.0361 | No |
| 109 | ARHGAP5 | NA | ARHGAP5 Entrez, Source | Rho GTPase activating protein 5 | 10376 | -0.040 | 0.0292 | No |
| 110 | ITGA4 | NA | ITGA4 Entrez, Source | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 10392 | -0.042 | 0.0287 | No |
| 111 | XIAP | NA | 10443 | -0.045 | 0.0262 | No | ||
| 112 | IBSP | NA | IBSP Entrez, Source | integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II) | 10657 | -0.058 | 0.0148 | No |
| 113 | PARVA | NA | PARVA Entrez, Source | parvin, alpha | 10887 | -0.070 | 0.0026 | No |
| 114 | LAMA2 | NA | LAMA2 Entrez, Source | laminin, alpha 2 (merosin, congenital muscular dystrophy) | 10978 | -0.076 | -0.0018 | No |
| 115 | PIK3R5 | NA | PIK3R5 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 11049 | -0.081 | -0.0050 | No |
| 116 | ACTN3 | NA | ACTN3 Entrez, Source | actinin, alpha 3 | 11241 | -0.094 | -0.0149 | No |
| 117 | ROCK2 | NA | ROCK2 Entrez, Source | Rho-associated, coiled-coil containing protein kinase 2 | 11260 | -0.095 | -0.0152 | No |
| 118 | DOCK1 | NA | DOCK1 Entrez, Source | dedicator of cytokinesis 1 | 11266 | -0.096 | -0.0147 | No |
| 119 | PDGFRA | NA | PDGFRA Entrez, Source | platelet-derived growth factor receptor, alpha polypeptide | 11392 | -0.105 | -0.0208 | No |
| 120 | PDPK1 | NA | PDPK1 Entrez, Source | 3-phosphoinositide dependent protein kinase-1 | 11449 | -0.110 | -0.0231 | No |
| 121 | ITGB5 | NA | ITGB5 Entrez, Source | integrin, beta 5 | 11562 | -0.120 | -0.0283 | No |
| 122 | PIK3CB | NA | PIK3CB Entrez, Source | phosphoinositide-3-kinase, catalytic, beta polypeptide | 11650 | -0.127 | -0.0322 | No |
| 123 | LAMA1 | NA | LAMA1 Entrez, Source | laminin, alpha 1 | 11699 | -0.132 | -0.0338 | No |
| 124 | PTK2 | NA | PTK2 Entrez, Source | PTK2 protein tyrosine kinase 2 | 11849 | -0.144 | -0.0410 | No |
| 125 | PTEN | NA | PTEN Entrez, Source | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 12081 | -0.162 | -0.0525 | No |
| 126 | PPP1R12A | NA | PPP1R12A Entrez, Source | protein phosphatase 1, regulatory (inhibitor) subunit 12A | 12216 | -0.174 | -0.0586 | No |
| 127 | PIK3R2 | NA | PIK3R2 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta) | 12247 | -0.177 | -0.0589 | No |
| 128 | PGF | NA | PGF Entrez, Source | placental growth factor, vascular endothelial growth factor-related protein | 12272 | -0.179 | -0.0588 | No |
| 129 | PARVG | NA | PARVG Entrez, Source | parvin, gamma | 12284 | -0.181 | -0.0580 | No |
| 130 | SOS1 | NA | SOS1 Entrez, Source | son of sevenless homolog 1 (Drosophila) | 12302 | -0.183 | -0.0575 | No |
| 131 | CDC42 | NA | CDC42 Entrez, Source | cell division cycle 42 (GTP binding protein, 25kDa) | 12435 | -0.196 | -0.0633 | No |
| 132 | KDR | NA | KDR Entrez, Source | kinase insert domain receptor (a type III receptor tyrosine kinase) | 12490 | -0.200 | -0.0648 | No |
| 133 | CTNNB1 | NA | CTNNB1 Entrez, Source | catenin (cadherin-associated protein), beta 1, 88kDa | 12660 | -0.216 | -0.0725 | No |
| 134 | RHOA | NA | RHOA Entrez, Source | ras homolog gene family, member A | 12705 | -0.219 | -0.0732 | No |
| 135 | FLT1 | NA | FLT1 Entrez, Source | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 12790 | -0.227 | -0.0761 | No |
| 136 | PPP1CB | NA | PPP1CB Entrez, Source | protein phosphatase 1, catalytic subunit, beta isoform | 12856 | -0.230 | -0.0779 | No |
| 137 | CAV2 | NA | CAV2 Entrez, Source | caveolin 2 | 12910 | -0.236 | -0.0789 | No |
| 138 | MYL12B | NA | 12935 | -0.238 | -0.0784 | No | ||
| 139 | VEGFB | NA | VEGFB Entrez, Source | vascular endothelial growth factor B | 12945 | -0.240 | -0.0770 | No |
| 140 | LAMC3 | NA | LAMC3 Entrez, Source | laminin, gamma 3 | 12947 | -0.240 | -0.0752 | No |
| 141 | PARVB | NA | PARVB Entrez, Source | parvin, beta | 13164 | -0.259 | -0.0852 | No |
| 142 | SHC4 | NA | SHC4 Entrez, Source | SHC (Src homology 2 domain containing) family, member 4 | 13233 | -0.266 | -0.0868 | No |
| 143 | TNN | NA | TNN Entrez, Source | tenascin N | 13301 | -0.272 | -0.0884 | No |
| 144 | LAMB2 | NA | LAMB2 Entrez, Source | laminin, beta 2 (laminin S) | 13505 | -0.292 | -0.0974 | No |
| 145 | MAPK9 | NA | MAPK9 Entrez, Source | mitogen-activated protein kinase 9 | 13521 | -0.294 | -0.0959 | No |
| 146 | FYN | NA | FYN Entrez, Source | FYN oncogene related to SRC, FGR, YES | 13562 | -0.297 | -0.0958 | No |
| 147 | RAC3 | NA | RAC3 Entrez, Source | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 13740 | -0.315 | -0.1032 | No |
| 148 | CHAD | NA | CHAD Entrez, Source | chondroadherin | 13827 | -0.323 | -0.1054 | No |
| 149 | RELN | NA | RELN Entrez, Source | reelin | 13877 | -0.328 | -0.1056 | No |
| 150 | RAF1 | NA | RAF1 Entrez, Source | v-raf-1 murine leukemia viral oncogene homolog 1 | 13934 | -0.335 | -0.1060 | No |
| 151 | CAV1 | NA | CAV1 Entrez, Source | caveolin 1, caveolae protein, 22kDa | 13996 | -0.345 | -0.1067 | No |
| 152 | GRB2 | NA | GRB2 Entrez, Source | growth factor receptor-bound protein 2 | 14005 | -0.345 | -0.1044 | No |
| 153 | MYL7 | NA | MYL7 Entrez, Source | myosin, light chain 7, regulatory | 14008 | -0.346 | -0.1018 | No |
| 154 | ITGAV | NA | ITGAV Entrez, Source | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 14332 | -0.383 | -0.1168 | No |
| 155 | MAPK10 | NA | MAPK10 Entrez, Source | mitogen-activated protein kinase 10 | 14334 | -0.383 | -0.1138 | No |
| 156 | RAP1A | NA | RAP1A Entrez, Source | RAP1A, member of RAS oncogene family | 14381 | -0.389 | -0.1133 | No |
| 157 | BCL2 | NA | BCL2 Entrez, Source | B-cell CLL/lymphoma 2 | 14397 | -0.390 | -0.1111 | No |
| 158 | MYL9 | NA | MYL9 Entrez, Source | myosin, light chain 9, regulatory | 14544 | -0.412 | -0.1159 | No |
| 159 | VEGFC | NA | VEGFC Entrez, Source | vascular endothelial growth factor C | 14653 | -0.425 | -0.1186 | No |
| 160 | VAV3 | NA | VAV3 Entrez, Source | vav 3 oncogene | 14722 | -0.432 | -0.1190 | No |
| 161 | ITGB3 | NA | ITGB3 Entrez, Source | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 14763 | -0.438 | -0.1178 | No |
| 162 | MAPK1 | NA | MAPK1 Entrez, Source | mitogen-activated protein kinase 1 | 14765 | -0.439 | -0.1144 | No |
| 163 | PDGFC | NA | PDGFC Entrez, Source | platelet derived growth factor C | 14827 | -0.451 | -0.1142 | No |
| 164 | RAP1B | NA | RAP1B Entrez, Source | RAP1B, member of RAS oncogene family | 14943 | -0.467 | -0.1169 | No |
| 165 | PPP1CC | NA | PPP1CC Entrez, Source | protein phosphatase 1, catalytic subunit, gamma isoform | 15049 | -0.482 | -0.1190 | No |
| 166 | SPP1 | NA | SPP1 Entrez, Source | secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 15059 | -0.484 | -0.1156 | No |
| 167 | TNC | NA | TNC Entrez, Source | tenascin C (hexabrachion) | 15273 | -0.513 | -0.1234 | No |
| 168 | PRKCB | NA | 15489 | -0.550 | -0.1311 | No | ||
| 169 | ACTN2 | NA | ACTN2 Entrez, Source | actinin, alpha 2 | 15627 | -0.577 | -0.1342 | No |
| 170 | GSK3B | NA | GSK3B Entrez, Source | glycogen synthase kinase 3 beta | 15693 | -0.588 | -0.1331 | No |
| 171 | COL11A1 | NA | COL11A1 Entrez, Source | collagen, type XI, alpha 1 | 15884 | -0.631 | -0.1387 | No |
| 172 | ITGA11 | NA | ITGA11 Entrez, Source | integrin, alpha 11 | 15895 | -0.632 | -0.1343 | No |
| 173 | COL11A2 | NA | COL11A2 Entrez, Source | collagen, type XI, alpha 2 | 15998 | -0.656 | -0.1348 | No |
| 174 | RASGRF1 | NA | RASGRF1 Entrez, Source | Ras protein-specific guanine nucleotide-releasing factor 1 | 16065 | -0.671 | -0.1332 | No |
| 175 | COL4A4 | NA | COL4A4 Entrez, Source | collagen, type IV, alpha 4 | 16105 | -0.682 | -0.1300 | No |
| 176 | THBS3 | NA | THBS3 Entrez, Source | thrombospondin 3 | 16137 | -0.689 | -0.1263 | No |
| 177 | SOS2 | NA | SOS2 Entrez, Source | son of sevenless homolog 2 (Drosophila) | 16328 | -0.741 | -0.1310 | No |
| 178 | ARHGAP35 | NA | 16487 | -0.793 | -0.1336 | No | ||
| 179 | PDGFD | NA | PDGFD Entrez, Source | platelet derived growth factor D | 16772 | -0.877 | -0.1424 | No |
| 180 | ITGB1 | NA | ITGB1 Entrez, Source | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 16942 | -0.944 | -0.1444 | No |
| 181 | LAMA3 | NA | LAMA3 Entrez, Source | laminin, alpha 3 | 16986 | -0.962 | -0.1392 | No |
| 182 | ITGA7 | NA | ITGA7 Entrez, Source | integrin, alpha 7 | 17088 | -1.007 | -0.1369 | No |
| 183 | MET | NA | MET Entrez, Source | met proto-oncogene (hepatocyte growth factor receptor) | 17207 | -1.062 | -0.1351 | No |
| 184 | THBS4 | NA | THBS4 Entrez, Source | thrombospondin 4 | 17229 | -1.076 | -0.1278 | No |
| 185 | LAMB1 | NA | LAMB1 Entrez, Source | laminin, beta 1 | 17257 | -1.095 | -0.1206 | No |
| 186 | COL6A6 | NA | 17427 | -1.205 | -0.1206 | No | ||
| 187 | COL5A2 | NA | COL5A2 Entrez, Source | collagen, type V, alpha 2 | 17557 | -1.302 | -0.1175 | No |
| 188 | COL3A1 | NA | COL3A1 Entrez, Source | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | 17611 | -1.363 | -0.1097 | No |
| 189 | PIK3CG | NA | PIK3CG Entrez, Source | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 17630 | -1.385 | -0.0998 | No |
| 190 | EGF | NA | EGF Entrez, Source | epidermal growth factor (beta-urogastrone) | 17704 | -1.472 | -0.0922 | No |
| 191 | AKT3 | NA | AKT3 Entrez, Source | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 17766 | -1.559 | -0.0833 | No |
| 192 | COL1A1 | NA | COL1A1 Entrez, Source | collagen, type I, alpha 1 | 17830 | -1.690 | -0.0735 | No |
| 193 | PRKCA | NA | PRKCA Entrez, Source | protein kinase C, alpha | 17892 | -1.832 | -0.0625 | No |
| 194 | PDGFRB | NA | PDGFRB Entrez, Source | platelet-derived growth factor receptor, beta polypeptide | 17904 | -1.866 | -0.0484 | No |
| 195 | ITGA2B | NA | ITGA2B Entrez, Source | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 18009 | -2.323 | -0.0358 | No |
| 196 | VTN | NA | VTN Entrez, Source | vitronectin | 18023 | -2.397 | -0.0177 | No |
| 197 | MYLK3 | NA | 18115 | -3.249 | 0.0029 | No |
